Biotricity, Inc. (BTCY) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Biotricity, Inc.

BTCY

OTC

Unprofitable

EPS improving

Unprofitable

EPS improving

10M

Medical - Devices

Next Earning date - 18 Aug 2025

10M

Medical - Devices

Next Earning date - 18 Aug 2025

0.39USD

-0.00 ( -0.52%)

Market Open

Relative Strenght

Volume Buzz

14%

Earning Acce

Yes

Dist 52w H.

58%

Overview Chart

Quote Panel

Updated July 12, 2025

1W 6.91 % 1M -25.96 % 3M -8.33 % 1Y -56.00 %

Key Metrics

Market Cap
9.53M
Shares Outstanding
24.75M
Share in Float
17.12M
Dividende
0

Earning Date
18 Aug 2025
Price Target
0.385
Average Volume
31493
Beta
1.234

Range
0.186-0.92
Industry
Medical - Devices
Website
https://www.biotricity.com
Sector
Healthcare

Quote Panel

Updated July 12, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

0.72x

P/S Ratio

-0.31x

P/B Ratio

-0.9

Debt/Equity

-80.4%

Net Margin

$-1.6

EPS

How BTCY compares to sector?

P/E Ratio

Fundamentals

Relative Strength

BTCY

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

BTCY

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$14M

295%

2025-Revenue

$0.43

-690%

2025-EPS

$14M

-15474%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

0.00(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q4.22

N/A

-0.54
vs -0.90

Q1.23

N/A

-0.54
vs -0.72

Q2.23

N/A

-0.07
vs -0.60

Q3.23

N/A

-0.44
vs -0.54

Q4.23

N/A

-0.34
vs -0.54

Q1.24

N/A

-0.47
vs -0.54

Q2.24

N/A

-0.49
vs -0.07

Q3.24

N/A

-0.07
vs -0.44

Q4.24

N/A

-0.05
vs -0.34

Q1.25

N/A

-0.11
vs -0.47

Sales Growth

YoY

Current

Estimates

Q4.22

+27%

2.5M vs 1.9M

Q1.23

+28%

2.7M vs 2.1M

Q2.23

+47%

3M vs 2.1M

Q3.23

+21%

2.9M vs 2.4M

Q4.23

+21%

3M vs 2.5M

Q1.24

+16%

3.2M vs 2.7M

Q2.24

+6%

3.2M vs 3M

Q3.24

+13%

3.3M vs 2.9M

Q4.24

+22%

3.6M vs 3M

Q1.25

+10%

3.5M vs 3.2M

Return on Equity

QoQ

Q1.23

+24%

0.24
vs 0.29

Q2.23

+15%

0.15
vs 0.24

Q3.23

+14%

0.14
vs 0.15

Q4.23

+11%

0.11
vs 0.14

Q1.24

+14%

0.14
vs 0.11

Q2.24

+13%

0.13
vs 0.14

Q3.24

+5%

0.05
vs 0.13

Q4.24

+4%

0.04
vs 0.05

Institutionnal Ownership

QoQ

Q4.22

29
vs 26

12%

Q1.23

29
vs 29

Q2.23

24
vs 29

-17%

Q3.23

22
vs 24

-8%

Q4.23

21
vs 22

-5%

Q1.24

17
vs 21

-19%

Q2.24

20
vs 17

18%

Q3.24

4
vs 20

-80%

Earnings Growth

Latest News

seekingalpha.com

5 hours ago

BTCY:CA - Earn Yield On Your Digital Gold

globenewswire.com

8 hours ago

Biotricity Recognized by Financial Times as One of 2025's Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period Analyzed

globenewswire.com

8 hours ago

Biotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease Management

globenewswire.com

8 hours ago

Biotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025

globenewswire.com

8 hours ago

Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11%

prnewswire.com

10 hours ago

Biotricity and B-Secur Partner to Launch the Most Comprehensive Device-Neutral Ambulatory Cardiac Monitoring Platform

Company Description

0.39USD

N/A

0.72x

-0.31x

-0.9

-80.4%

$-1.6

$14M

$0.43

$14M

Earnings Growth

Latest News

$14M

$0.43

$14M

Company Description

0.39USD

N/A

0.72x

-0.31x

-0.9

-80.4%

$-1.6